3.1400
+0.6900
+(28.16%)
At close: January 23 at 7:00:00 PM EST
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
9,643,128.0000
9,643,128.0000
9,131,852.0000
8,705,817.0000
7,776,854.0000
Cost of Revenue
6,424,596.0000
6,424,596.0000
5,944,832.0000
5,648,062.0000
5,094,079.0000
Gross Profit
3,218,532.0000
3,218,532.0000
3,187,020.0000
3,057,755.0000
2,682,775.0000
Operating Expense
2,033,755.0000
2,033,755.0000
2,050,649.0000
1,985,695.0000
1,786,118.0000
Operating Income
1,184,777.0000
1,184,777.0000
1,136,371.0000
1,072,060.0000
896,657.0000
Net Non Operating Interest Income Expense
-86,758.0000
-86,758.0000
-52,167.0000
-40,906.0000
-43,667.0000
Pretax Income
1,124,821.0000
1,124,821.0000
1,205,582.0000
1,101,994.0000
905,876.0000
Tax Provision
310,812.0000
310,812.0000
307,222.0000
301,265.0000
243,764.0000
Net Income Common Stockholders
814,009.0000
814,009.0000
898,410.0000
800,345.0000
657,463.0000
Diluted NI Available to Com Stockholders
814,009.0000
814,009.0000
898,410.0000
800,345.0000
657,463.0000
Basic EPS
6.17
6.17
5.61
4.95
3.96
Diluted EPS
6.01
6.01
5.49
4.86
3.96
Basic Average Shares
150,842.1290
150,842.1290
160,064.8750
161,758.6740
165,888.0000
Diluted Average Shares
154,632.7600
154,632.7600
163,753.7750
164,769.6860
165,971.0000
Total Operating Income as Reported
1,064,824.0000
1,064,824.0000
1,135,527.0000
1,052,820.0000
849,755.0000
Rent Expense Supplemental
48,654.0000
--
--
--
--
Total Expenses
8,458,351.0000
8,458,351.0000
7,995,481.0000
7,633,757.0000
6,880,197.0000
Net Income from Continuing & Discontinued Operation
814,009.0000
814,009.0000
898,410.0000
800,345.0000
657,463.0000
Normalized Income
897,706.2960
897,706.2960
898,410.0000
808,705.5000
690,807.5650
Interest Income
9,651.0000
9,651.0000
6,846.0000
3,536.0000
3,236.0000
Interest Expense
97,462.0000
97,462.0000
59,664.0000
45,401.0000
47,953.0000
Net Interest Income
-86,758.0000
-86,758.0000
-52,167.0000
-40,906.0000
-43,667.0000
EBIT
1,222,283.0000
1,222,283.0000
1,265,246.0000
1,147,395.0000
953,829.0000
EBITDA
1,422,897.0000
1,422,897.0000
1,463,280.0000
1,340,052.0000
1,148,968.0000
Reconciled Cost of Revenue
6,424,596.0000
6,424,596.0000
5,944,832.0000
5,648,062.0000
5,094,079.0000
Reconciled Depreciation
200,614.0000
200,614.0000
198,034.0000
192,657.0000
195,139.0000
Net Income from Continuing Operation Net Minority Interest
814,009.0000
814,009.0000
898,410.0000
800,345.0000
657,463.0000
Total Unusual Items Excluding Goodwill
-115,604.0000
-115,604.0000
--
-11,500.0000
-45,615.0000
Total Unusual Items
-115,604.0000
-115,604.0000
--
-11,500.0000
-45,615.0000
Normalized EBITDA
1,538,501.0000
1,538,501.0000
1,463,280.0000
1,351,552.0000
1,194,583.0000
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
-31,906.7040
-31,906.7040
--
-3,139.5000
-12,270.4350
6/30/2021 - 6/12/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
183490.KQ Enzychem Lifesciences Corporation
1,540.00
+2.67%
CCC.JO Cilo Cybin Holdings Ltd
400.00
-24.39%
ASC.JO Ascendis Health Limited
85.00
0.00%
APN.JO Aspen Pharmacare Holdings Limited
17,307.00
+1.02%
TRUFF Red Light Holland Corp.
0.0321
0.00%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.7830
-10.51%
AKAN Akanda Corp.
1.7900
+8.48%
FLGC Flora Growth Corp.
0.7902
-3.87%
TLRY Tilray Brands, Inc.
1.0900
-0.91%